{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:44:16Z","timestamp":1790959456191,"version":"4.1.0"},"reference-count":170,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Colloid and Interface Science"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.cis.2018.01.003","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T08:09:37Z","timestamp":1517990977000},"page":"35-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Prodrugs, phospholipids and vesicular delivery - An effective triumvirate of pharmacosomes"],"prefix":"10.1016","volume":"253","author":[{"given":"Bhupinder","family":"Kapoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saranjit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cis.2018.01.003_bb0005","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1517\/17425247.3.5.629","article-title":"Pharmaceutical nanotechnology: polymeric vesicles for drug and gene delivery","volume":"3","author":"Uchegbu","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.cis.2018.01.003_bb0010","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1166\/jbn.2010.1151","article-title":"Biphasic vesicles: a novel topical drug delivery system","volume":"6","author":"Foldvari","year":"2010","journal-title":"J Biomed Nanotechnol"},{"key":"10.1016\/j.cis.2018.01.003_bb0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.apsb.2011.09.002","article-title":"Nonionic surfactant vesicular systems for effective drug delivery\u2014an overview","volume":"1","author":"Kumar","year":"2011","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.cis.2018.01.003_bb0020","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1631\/jzus.B1200098","article-title":"Docetaxel-loaded liposomes: preparation, pH sensitivity, pharmacokinetics, and tissue distribution","volume":"13","author":"Zhang","year":"2012","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.cis.2018.01.003_bb0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/2211362611201010015","article-title":"Preclinical and clinical aspects of antimicrobial drugs delivered through ethosomal vesicles","volume":"10","author":"Akhtar","year":"2012","journal-title":"Anti-Infect Agents"},{"key":"10.1016\/j.cis.2018.01.003_bb0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2014.04.015","article-title":"Nano-niosomes as nanoscale drug delivery systems: an illustrated review","volume":"185","author":"Moghassemi","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2018.01.003_bb0035","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0014-5793(73)80394-1","article-title":"Drug entrapment in liposomes","volume":"36","author":"Gregoriadis","year":"1973","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cis.2018.01.003_bb0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0378-5173(98)00169-0","article-title":"Non-ionic surfactant based vesicles (niosomes) in drug delivery","volume":"172","author":"Uchegbu","year":"1998","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0045","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0168-3659(99)00222-9","article-title":"Ethosomes\u2014novel vesicular carriers for enhanced delivery: characterization and skin penetration properties","volume":"65","author":"Touitou","year":"2000","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2018.01.003_bb0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0005-2736(92)90154-E","article-title":"Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force","volume":"1104","author":"Cevc","year":"1992","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10.1016\/j.cis.2018.01.003_bb0055","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.colsurfb.2011.12.004","article-title":"A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro\/in vivo evaluation","volume":"92","author":"Song","year":"2012","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.cis.2018.01.003_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejpb.2016.04.023","article-title":"Development and characterization of novel 1-(1-Naphthyl) piperazine-loaded lipid vesicles for prevention of UV-induced skin inflammation","volume":"104","author":"Menezes","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0065","first-page":"226","article-title":"Activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts","volume":"14","author":"Bioavailability","year":"2009","journal-title":"Altern Med Rev"},{"key":"10.1016\/j.cis.2018.01.003_bb0070","first-page":"2385","article-title":"Lyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: optimization and ex vivo permeation","volume":"8","author":"Freag","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cis.2018.01.003_bb0075","series-title":"Penetration enhancer-containing vesicles for cutaneous drug delivery. Percutaneous penetration enhancers chemical methods in penetration enhancement","author":"Manconi","year":"2016"},{"key":"10.1016\/j.cis.2018.01.003_bb0080","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijpharm.2015.05.042","article-title":"LeciPlex, invasomes, and liposomes: a skin penetration study","volume":"490","author":"Shah","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0085","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ijpharm.2017.06.037","article-title":"Tocosome: novel drug delivery system containing phospholipids and tocopheryl phosphates","volume":"528","author":"Mozafari","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0090","first-page":"163","article-title":"Pharmacosomes, a novel drug delivery system","volume":"23","author":"Vaizoglu","year":"1986","journal-title":"Acta Pharm Suec"},{"key":"10.1016\/j.cis.2018.01.003_bb0095","series-title":"Polymeric biomaterials","article-title":"Liposomes in drug delivery","author":"Zhang","year":"2002"},{"key":"10.1016\/j.cis.2018.01.003_bb0100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.cis.2018.01.003_bb0105","first-page":"402","article-title":"Stability aspects of liposomes","volume":"45","author":"Yadav","year":"2011","journal-title":"Indian J Pharm Educ Res"},{"key":"10.1016\/j.cis.2018.01.003_bb0110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajps.2013.07.011","article-title":"Liposomes as sterile preparations and limitations of sterilisation techniques in liposomal manufacturing","volume":"8","author":"Toh","year":"2013","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.cis.2018.01.003_bb0115","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/591325","article-title":"Liposome technology for industrial purposes","author":"Wagner","year":"2011","journal-title":"J Drug Delivery"},{"key":"10.1016\/j.cis.2018.01.003_bb0120","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1039\/C5BM00481K","article-title":"Biodegradable liposome-encapsulated hydrogels for biomedical applications: a marriage of convenience","volume":"4","author":"Grijalvo","year":"2016","journal-title":"Biomater Sci"},{"key":"10.1016\/j.cis.2018.01.003_bb0125","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0009-3084(85)90087-8","article-title":"Phase behaviour of a diglyceride prodrug: spontaneous formation of unilamellar vesicles","volume":"37","author":"Mantelli","year":"1985","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.cis.2018.01.003_bb0130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-5173(98)00006-4","article-title":"Lipophilic drug derivatives in liposomes","volume":"165","author":"Gulati","year":"1998","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1567201052772870","article-title":"Comparative study of different silymarin formulations: formulation, characterisation and in vitro\/in vivo evaluation","volume":"2","author":"Abrol","year":"2005","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.cis.2018.01.003_bb0140","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1517\/17425240902967607","article-title":"Pharmacosomes: the lipid-based new drug delivery system","volume":"6","author":"Semalty","year":"2009","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.cis.2018.01.003_bb0145","first-page":"193","article-title":"Novel vesicular system: an overview","volume":"2","author":"Jadhav","year":"2012","journal-title":"J Appl Pharm Sci"},{"key":"10.1016\/j.cis.2018.01.003_bb0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1470-8744.1999.tb00903.x","article-title":"Dermal and transdermal delivery of protein pharmaceuticals: lipid-based delivery systems for interferon alpha","volume":"30","author":"Foldvari","year":"1999","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.cis.2018.01.003_bb0155","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0002-9343(70)80127-9","article-title":"The characteristics of mixed micellar solutions with particular reference to bile","volume":"49","author":"Carey","year":"1970","journal-title":"Am J Med"},{"key":"10.1016\/j.cis.2018.01.003_bb0160","series-title":"Transdermal nanocarriers. Current technologies to increase the transdermal delivery of drugs","author":"D\u00edaz-Torres","year":"2010"},{"issue":"2","key":"10.1016\/j.cis.2018.01.003_bb0165","doi-asserted-by":"crossref","first-page":"S1176","DOI":"10.1016\/S2221-1691(12)60381-5","article-title":"Recent advances in various emerging vescicular systems: an overview","author":"Gangwar","year":"2012","journal-title":"Asian Pac J Trop Biomed"},{"key":"10.1016\/j.cis.2018.01.003_bb0170","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2174\/22117385113016660008","article-title":"Formulation and clinical evaluation of triamcinolone acetonide niosomes: effect of iontophoresis on the permeation across skin","volume":"1","author":"Sankar","year":"2013","journal-title":"Pharm Nanotechnol"},{"key":"10.1016\/j.cis.2018.01.003_bb0175","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v28.i4.20","article-title":"Lipid nanocarriers: influence of lipids on product development and pharmacokinetics","volume":"28","author":"Pathak","year":"2011","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1016\/j.cis.2018.01.003_bb0180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1387-2656(01)07033-8","article-title":"Liposomes as drug carriers: a technological approach","volume":"7","author":"Brandl","year":"2001","journal-title":"Biotechnol Annu Rev"},{"key":"10.1016\/j.cis.2018.01.003_bb0185","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ejps.2011.09.013","article-title":"Phospholipase A 2-susceptible liposomes of anticancer double lipid-prodrugs","volume":"45","author":"Arouri","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.cis.2018.01.003_bb0190","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.colsurfb.2013.08.021","article-title":"Nanoassemblies containing a fluorouracil\/zidovudine glyceryl prodrug with phospholipase A2-triggered drug release for cancer treatment","volume":"112","author":"Jin","year":"2013","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.cis.2018.01.003_bb0195","first-page":"111","article-title":"Factors affecting drug release from liposomes","volume":"13","author":"Lindner","year":"2010","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1016\/j.cis.2018.01.003_bb0200","article-title":"Pharmacosomes: an emerging novel vesicular drug delivery system for poorly soluble synthetic and herbal drugs","author":"Pandita","year":"2013","journal-title":"ISRN Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0205","first-page":"431","article-title":"Phytosome: new cosmetic delivery system","volume":"130","author":"Bombardelli","year":"1991","journal-title":"Boll Chim Farm"},{"key":"10.1016\/j.cis.2018.01.003_bb0210","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10637-006-9019-2","article-title":"A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients","volume":"25","author":"Flaig","year":"2007","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.cis.2018.01.003_bb0215","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1039\/c2ra20653f","article-title":"Catanionic vesicles from an amphiphilic prodrug molecule: a new concept for drug delivery systems","volume":"2","author":"Jiang","year":"2012","journal-title":"RSC Adv"},{"key":"10.1016\/j.cis.2018.01.003_bb0220","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/jps.2600830907","article-title":"Synthesis of the cholesteryl ester prodrugs cholesteryl ibuprofen and cholesteryl flufenamate and their formulation into phospholipid microemulsions","volume":"83","author":"Murtha","year":"1994","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.cis.2018.01.003_bb0225","article-title":"Synthesis and characterization of ganciclovir long chain lipid prodrugs","volume":"1","author":"Cholkar","year":"2014","journal-title":"Adv Ophthalmol Vis Syst"},{"key":"10.1016\/j.cis.2018.01.003_bb0230","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1021\/mp500359a","article-title":"Prodrugs of pioglitazone for extended-release (XR) injectable formulations","volume":"11","author":"Sanrame","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0235","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1021\/jm00362a021","article-title":"1,3-Dipalmitoylglycerol ester of chlorambucil as a lymphotropic, orally administrable antineoplastic agent","volume":"26","author":"Garzon-Aburbeh","year":"1983","journal-title":"J Med Chem"},{"key":"10.1016\/j.cis.2018.01.003_bb0240","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0099-5428(08)60554-7","article-title":"Chlorambucil","volume":"16","author":"Tariq","year":"1987","journal-title":"Anal Profiles Drug Subst"},{"key":"10.1016\/j.cis.2018.01.003_bb0245","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0099-5428(08)60268-3","article-title":"Flufenamic acid","volume":"11","author":"Abignente","year":"1982","journal-title":"Anal Profiles Drug Subst"},{"key":"10.1016\/j.cis.2018.01.003_bb0250","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0099-5428(08)60682-6","article-title":"Analytical profile of 5-fluorouracil","volume":"18","author":"Bayomi","year":"1990","journal-title":"Anal Profiles Drug Subst"},{"key":"10.1016\/j.cis.2018.01.003_bb0255","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1134\/S1068162013030138","article-title":"Synthesis and properties of lipophilic derivatives of 5-fluorouracil","volume":"39","author":"Semakov","year":"2013","journal-title":"Russ J Bioorg Chem"},{"key":"10.1016\/j.cis.2018.01.003_bb0260","doi-asserted-by":"crossref","first-page":"13177","DOI":"10.3390\/molecules190913177","article-title":"Design and synthesis of new cholesterol-conjugated 5-fluorouracil: a novel potential delivery system for cancer treatment","volume":"19","author":"Radwan","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.cis.2018.01.003_bb0265","doi-asserted-by":"crossref","first-page":"10296","DOI":"10.3390\/ijms130810296","article-title":"Effects of humidity and surfaces on the melt crystallization of ibuprofen","volume":"13","author":"Lee","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cis.2018.01.003_bb0270","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejmech.2004.11.009","article-title":"Synthesis, pharmacological activity and hydrolytic behavior of glyceride prodrugs of ibuprofen","volume":"40","author":"Khan","year":"2005","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.cis.2018.01.003_bb0275","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0378-5173(83)90067-4","article-title":"Development of lipophilic prodrugs of mitomycin C. II. Stability and bioactivation of 1a-N-substituted derivatives with aromatic pro-moiety","volume":"15","author":"Hitoshi","year":"1983","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0280","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1021\/jm950620o","article-title":"Nucleoside conjugates. 15. Synthesis and biological activity of anti-HIV nucleoside conjugates of ether and Thioether phospholipids","volume":"39","author":"Hong","year":"1996","journal-title":"J Med Chem"},{"key":"10.1016\/j.cis.2018.01.003_bb0285","series-title":"Pioglitazone. Profiles of drug substances, excipients and related methodology","volume":"Vol. 41","author":"Al-Majed","year":"2016"},{"key":"10.1016\/j.cis.2018.01.003_bb0290","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0378-5173(93)90373-N","article-title":"Melting point phase diagrams of free base and hydrochloride salts of bevantolol, pindolol and propranolol","volume":"99","author":"Neau","year":"1993","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0295","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0378-5173(99)00166-0","article-title":"Synthesis and characterisation of palymitoyl propanolol hydrochloride auto-lymphotrophs for oral administration","volume":"186","author":"Vyas","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0300","series-title":"Functional group considerations in the development of prodrug apprachs to solving topical delivery problems. Prodrugs: topical and ocular drug delivery","volume":"Vol. 53","author":"Sloan","year":"1992"},{"key":"10.1016\/j.cis.2018.01.003_bb0305","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1002\/jps.20634","article-title":"Estimation of melting points of organic compounds-II","volume":"95","author":"Jain","year":"2006","journal-title":"Pharm Sci"},{"key":"10.1016\/j.cis.2018.01.003_bb0310","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1208\/s12249-012-9916-y","article-title":"Thermal stability and decomposition kinetic studies of acyclovir and zidovudine drug compounds","volume":"14","author":"Shamsipur","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.cis.2018.01.003_bb0315","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.chroma.2011.01.077","article-title":"Thin layer chromatography\/mass spectrometry","volume":"1218","author":"Cheng","year":"2011","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.cis.2018.01.003_bb0320","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejphar.2014.03.019","article-title":"Esters of valerenic acid as potential prodrugs","volume":"735","author":"Hintersteiner","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cis.2018.01.003_bb0325","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0009-9120(78)90112-1","article-title":"A rapid, sensitive method for accurate analysis of individual bile acids in biological fluids by high performance thin-layer chromatography and densitometry","volume":"11","author":"Shepherd","year":"1978","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cis.2018.01.003_bb0330","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpha.2014.06.002","article-title":"Bioautography and its scope in the field of natural product chemistry","volume":"5","author":"Dewanjee","year":"2015","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.cis.2018.01.003_bb0335","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12257-011-0483-y","article-title":"Regioselective enzymatic procedure for preparing 3\u2032-O-stearoyl-6-azauridine by using Burkholderia cepacia lipase","volume":"17","author":"Wang","year":"2012","journal-title":"Biotechnol Bioprocess Eng"},{"key":"10.1016\/j.cis.2018.01.003_bb0340","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.chemphyslip.2011.02.001","article-title":"Lipase-catalyzed synthesis and characterization of 1-butanoyl-2-palmitoyl phosphatidylcholine, a potential lipidic prodrug of butyric acid","volume":"164","author":"Kaki","year":"2011","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.cis.2018.01.003_bb0345","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1039\/C6TB00612D","article-title":"Tunable self-assembly of Irinotecan-fatty acid prodrugs with increased cytotoxicity to cancer cells","volume":"4","author":"Zhang","year":"2016","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.cis.2018.01.003_bb0350","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.chroma.2003.08.072","article-title":"Reversed-phase high-performance liquid chromatography of polar lipids: II. Procedure for a phospholipid derivative of methotrexate","volume":"1031","author":"Ioffe","year":"2004","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.cis.2018.01.003_bb0355","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1773-2247(09)50007-X","article-title":"Liposomes loaded with lipophilic prodrugs of methotrexate and melphalan as convenient drug delivery vehicles","volume":"19","author":"Kuznetsova","year":"2009","journal-title":"J Drug Delivery Sci Technol"},{"key":"10.1016\/j.cis.2018.01.003_bb0360","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s11095-004-7667-5","article-title":"A folate receptor\u2013targeted lipid nanoparticle formulation for a lipophilic paclitaxel prodrug","volume":"21","author":"Stevens","year":"2004","journal-title":"Pharm Res"},{"key":"10.1016\/j.cis.2018.01.003_bb0365","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s12010-011-9333-9","article-title":"Highly regioselective synthesis of 3\u2032-O-acyl-trifluridines catalyzed by Pseudomonas cepacia lipase","volume":"165","author":"Wang","year":"2011","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.cis.2018.01.003_bb0370","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0378-5173(96)04720-5","article-title":"Synthesis and evaluation of 5\u2032 alkyl ester prodrugs of zidovudine for directed lymphatic delivery","volume":"144","author":"Bibby","year":"1996","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0375","doi-asserted-by":"crossref","first-page":"16489","DOI":"10.3390\/molecules191016489","article-title":"Modern prodrug design for targeted oral drug delivery","volume":"19","author":"Dahan","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.cis.2018.01.003_bb0380","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ajps.2014.09.004","article-title":"A review on phospholipids and their main applications in drug delivery systems","volume":"10","author":"Li","year":"2015","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.cis.2018.01.003_bb0385","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2147\/IJN.S39526","article-title":"A novel drug\u2013phospholipid complex enriched with micelles: preparation and evaluation in vitro and in vivo","volume":"8","author":"Xia","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cis.2018.01.003_bb0390","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.colsurfb.2005.02.001","article-title":"Langmuir monolayers of the long-chain alkyl derivatives of a nucleoside analogue and the formation of self-assembled nanoparticles","volume":"42","author":"Jin","year":"2005","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.cis.2018.01.003_bb0395","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijpharm.2007.08.037","article-title":"Self-assembled drug delivery systems: 2. Cholesteryl derivatives of antiviral nucleoside analogues: synthesis, properties and the vesicle formation","volume":"350","author":"Jin","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0400","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s10953-013-9995-8","article-title":"Comparison of aqueous and 1-octanol solubility as well as liquid\u2013liquid distribution of acyclovir derivatives and their complexes with hydroxypropyl-\u03b2-cyclodextrin","volume":"42","author":"Ko\u017abia\u0142","year":"2013","journal-title":"J Solution Chem"},{"key":"10.1016\/j.cis.2018.01.003_bb0405","series-title":"Anal. Profiles Drug Subst. Excipients","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0099-5428(08)60242-7","article-title":"Didanosine","volume":"22","author":"Nassar","year":"1993"},{"key":"10.1016\/j.cis.2018.01.003_bb0410","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1023\/A:1023207118209","article-title":"Topical delivery of 5-fluorouracil and 6-mercaptopurine by their alkylcarbonyloxymethyl prodrugs from water: vehicle effects on design of prodrugs","volume":"20","author":"Sloan","year":"2003","journal-title":"Pharm Res"},{"key":"10.1016\/j.cis.2018.01.003_bb0415","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1007\/s11095-006-9108-0","article-title":"Design for optimized topical delivery: prodrugs and a paradigm change","volume":"23","author":"Sloan","year":"2006","journal-title":"Pharm Res"},{"key":"10.1016\/j.cis.2018.01.003_bb0420","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1063\/1.555833","article-title":"Octanol-water partition coefficients of simple organic compounds","volume":"18","author":"Sangster","year":"1989","journal-title":"J Phys Chem Ref Data Monogr"},{"key":"10.1016\/j.cis.2018.01.003_bb0425","first-page":"1571","article-title":"Evaluation of lipophilicity, antimicrobial activity and mutagenicity of some novel ester prodrugs of metronidazole","volume":"48B","author":"Dubey","year":"2009","journal-title":"Indian J Chem"},{"key":"10.1016\/j.cis.2018.01.003_bb0430","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.apsb.2014.03.002","article-title":"Combined use of phospholipid complexes and self-emulsifying microemulsions for improving the oral absorption of a BCS class IV compound, baicalin","volume":"4","author":"Wu","year":"2014","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.cis.2018.01.003_bb0435","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpharm.2005.01.023","article-title":"Comparison of the octanol\/water partition coefficients calculated by ClogP, ACDlogP and KowWin to experimentally determined values","volume":"294","author":"Machatha","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0440","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejpb.2014.12.014","article-title":"Lipophilic prodrugs of apomorphine I: preparation, characterisation, and in vitro enzymatic hydrolysis in biorelevant media","volume":"89","author":"Borkar","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0445","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.colsurfb.2015.10.034","article-title":"Spiral assembly of amphiphilic cytarabine prodrug assisted by probe sonication: enhanced therapy index for leukemia","volume":"136","author":"Liu","year":"2015","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.cis.2018.01.003_bb0450","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.ejmech.2011.02.056","article-title":"Fatty acyl amide derivatives of doxorubicin: synthesis and in vitro anticancer activities","volume":"46","author":"Chhikara","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.cis.2018.01.003_bb0455","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1248\/cpb.35.4898","article-title":"Disposition characteristics of lipophilic mitomycin C prodrug in an intra-arterial muscle infusion system","volume":"35","author":"Kakutani","year":"1987","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.cis.2018.01.003_bb0460","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/A:1011018730459","article-title":"Synthesis and study of 5\u2032-ester prodrugs of N6-cyclopentyladenosine, a selective A1 receptor agonist","volume":"18","author":"Dalpiaz","year":"2001","journal-title":"Pharm Res"},{"key":"10.1016\/j.cis.2018.01.003_bb0465","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2012.06.034","article-title":"Squalenoyl prodrug of paclitaxel: synthesis and evaluation of its incorporation in phospholipid bilayers","volume":"436","author":"Sarpietro","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0470","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijpharm.2014.09.022","article-title":"Lipophilic prodrug of paclitaxel: interaction with a dimyristoylphosphatidylcholine monolayer","volume":"475","author":"Giuffrida","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0475","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijpharm.2009.11.026","article-title":"Preparation and evaluation of self-nanoemulsified drug delivery systems (SNEDDSs) of matrine based on drug\u2013phospholipid complex technique","volume":"386","author":"Ruan","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0480","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0731-7085(97)00276-8","article-title":"NMR spectroscopy in pharmacy","volume":"17","author":"Holzgrabe","year":"1998","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.cis.2018.01.003_bb0485","first-page":"35","article-title":"Preparation and properties of a silybin-phospholipid complex","volume":"63","author":"Song","year":"2008","journal-title":"Die Pharmazie Int J Pharm Sci"},{"key":"10.1016\/j.cis.2018.01.003_bb0490","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0005-2736(00)00359-X","article-title":"Characterization of sterically stabilized cisplatin liposomes by nuclear magnetic resonance","volume":"1510","author":"Peleg-Shulman","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cis.2018.01.003_bb0495","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1021\/bi951999j","article-title":"Poly (ethylene glycol)-lipid conjugates promote bilayer formation in mixtures of non-bilayer-forming lipids","volume":"35","author":"Holland","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.cis.2018.01.003_bb0500","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/aps.2009.171","article-title":"Preparation, characterization and in vivo evaluation of bergenin-phospholipid complex","volume":"31","author":"Qin","year":"2010","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.cis.2018.01.003_bb0505","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10847-010-9824-2","article-title":"Preparation & characterization of embelin\u2013phospholipid complex as effective drug delivery tool","volume":"69","author":"Pathan","year":"2011","journal-title":"J Inclusion Phenom Macrocyclic Chem"},{"key":"10.1016\/j.cis.2018.01.003_bb0510","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/0975-7406.76463","article-title":"Differential scanning calorimetry: an invaluable tool for a detailed thermodynamic characterization of macromolecules and their interactions","volume":"3","author":"Chiu","year":"2011","journal-title":"J Pharm Bioallied Sci"},{"key":"10.1016\/j.cis.2018.01.003_bb0515","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1021\/la960370u","article-title":"Differentiating unilamellar, multilamellar, and oligovesicular vesicles using a fluorescent dye","volume":"12","author":"Menger","year":"1996","journal-title":"Langmuir"},{"key":"10.1016\/j.cis.2018.01.003_bb0520","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijpharm.2010.12.021","article-title":"Microscopy imaging of liposomes: from coverslips to environmental SEM","volume":"417","author":"Bibi","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/acph-2016-0003","article-title":"Microscopic methods in analysis of submicron phospholipid dispersions","volume":"66","author":"Placzek","year":"2016","journal-title":"Acta Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0530","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0927-7757(00)00516-1","article-title":"Cryo transmission electron microscopy of liposomes and related structures","volume":"174","author":"Almgren","year":"2000","journal-title":"Colloids Surf A"},{"key":"10.1016\/j.cis.2018.01.003_bb0535","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/anie.200805241","article-title":"Drug delivery by an enzyme-mediated cyclization of a lipid prodrug with unique bilayer-formation properties","volume":"48","author":"Linderoth","year":"2009","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.cis.2018.01.003_bb0540","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/08982100601186508","article-title":"Environmental scanning electron microscopy offers real-time morphological analysis of liposomes and niosomes","volume":"17","author":"Perrie","year":"2007","journal-title":"J Liposome Res"},{"key":"10.1016\/j.cis.2018.01.003_bb0545","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2147\/IJN.S14615","article-title":"AFM, ESEM, TEM, and CLSM in liposomal characterization: a comparative study","volume":"6","author":"Ruozi","year":"2011","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cis.2018.01.003_bb0550","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijpharm.2013.10.043","article-title":"Novel rifampicin\u2013phospholipid complex for tubercular therapy: synthesis, physicochemical characterization and in-vivo evaluation","volume":"460","author":"Singh","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0555","first-page":"1363","article-title":"Formulation and evaluation of pharmacosomes of ketoprofen","volume":"4","author":"Kamalesh","year":"2014","journal-title":"Indo Am J Pharm Res"},{"key":"10.1016\/j.cis.2018.01.003_bb0560","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0021-9797(74)90337-3","article-title":"Hydrodynamic chromatography a technique for size analysis of colloidal particles","volume":"48","author":"Small","year":"1974","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.cis.2018.01.003_bb0565","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1208\/pt030207","article-title":"Determination of the size distribution of liposomes by SEC fractionation, and PCS analysis and enzymatic assay of lipid content","volume":"3","author":"Ingebrigtsen","year":"2002","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.cis.2018.01.003_bb0570","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1166\/jnn.2006.454","article-title":"Liposome size analysis by dynamic\/static light scattering upon size exclusion-\/field flow-fractionation","volume":"6","author":"Hupfeld","year":"2006","journal-title":"J Nanosci Nanotechnol"},{"key":"10.1016\/j.cis.2018.01.003_bb0575","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.chroma.2015.10.029","article-title":"Application of asymmetric flow field-flow fractionation hyphenations for liposome\u2013antimicrobial peptide interaction","volume":"1422","author":"Iavicoli","year":"2015","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.cis.2018.01.003_bb0580","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2174\/157341311795542453","article-title":"Liposomes: a review of manufacturing techniques and targeting strategies","volume":"7","author":"Maherani","year":"2011","journal-title":"Curr Nanosci"},{"key":"10.1016\/j.cis.2018.01.003_bb0585","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1021\/la00053a018","article-title":"Evaluation of phase transition temperature of liposomes by using tautomerism of benzoylacetoanilide and effects of cholesterol","volume":"7","author":"Ueno","year":"1991","journal-title":"Langmuir"},{"key":"10.1016\/j.cis.2018.01.003_bb0590","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbamem.2005.04.011","article-title":"Observation of the main phase transition of dinervonoylphosphocholine giant liposomes by fluorescence microscopy","volume":"1713","author":"Metso","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cis.2018.01.003_bb0595","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0009-3084(00)00220-6","article-title":"Parameters influencing the determination of liposome lamellarity by 31 P-NMR","volume":"109","author":"Fr\u00f6hlich","year":"2001","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.cis.2018.01.003_bb0600","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bpj.2014.05.039","article-title":"Quantitative analysis of the lamellarity of giant liposomes prepared by the inverted emulsion method","volume":"107","author":"Chiba","year":"2014","journal-title":"Biophys J"},{"key":"10.1016\/j.cis.2018.01.003_bb0605","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0009-3084(93)90053-6","article-title":"Chemical stability of liposomes: implications for their physical stability","volume":"64","author":"Grit","year":"1993","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.cis.2018.01.003_bb0610","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1021\/jm900091h","article-title":"Synthesis and biophysical characterization of chlorambucil anticancer ether lipid prodrugs","volume":"52","author":"Pedersen","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.cis.2018.01.003_bb0615","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2478\/v10007-009-0023-x","article-title":"Development and physicochemical evaluation of pharmacosomes of diclofenac","volume":"59","author":"Semalty","year":"2009","journal-title":"Acta Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0620","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4103\/0250-474X.78523","article-title":"Development and evaluation of pharmacosomes of aceclofenac","volume":"72","author":"Semalty","year":"2010","journal-title":"Indian J Pharm Sci"},{"key":"10.1016\/j.cis.2018.01.003_bb0625","first-page":"940","article-title":"Development and characterization of aspirin-phospholipid complex for improved drug delivery","volume":"3","author":"Semalty","year":"2010","journal-title":"Int J Pharm Sci Nanotechnol"},{"key":"10.1016\/j.cis.2018.01.003_bb0630","first-page":"456","article-title":"Optimization of the preparation of 3\u2032,5\u2032-dioctanoyl-5-fluoro-2\u2032-deoxyuridine pharmacosomes using central composite design","volume":"36","author":"Zhang","year":"2001","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/j.cis.2018.01.003_bb0635","first-page":"771","article-title":"Study on brain targeting 3\u2032,5\u2032-dioctanoyl-5-fluoro-2\u2032-deoxyuridine pharmacosomes","volume":"36","author":"Zhang","year":"2001","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/j.cis.2018.01.003_bb0640","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1021\/jm031029r","article-title":"Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs","volume":"47","author":"Andresen","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.cis.2018.01.003_bb0645","doi-asserted-by":"crossref","first-page":"7305","DOI":"10.1021\/jm049006f","article-title":"Synthesis and biological activity of anticancer ether lipids that are specifically released by phospholipase A2 in tumor tissue","volume":"48","author":"Andresen","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.cis.2018.01.003_bb0650","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1016\/j.bmcl.2010.06.054","article-title":"Prostaglandin phospholipid conjugates with unusual biophysical and cytotoxic properties","volume":"20","author":"Pedersen","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cis.2018.01.003_bb0655","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1021\/jm100190c","article-title":"Liposomal formulation of retinoids designed for enzyme triggered release","volume":"53","author":"Pedersen","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.cis.2018.01.003_bb0660","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3109\/08982104.2011.563365","article-title":"Anticancer double lipid prodrugs: liposomal preparation and characterization","volume":"21","author":"Arouri","year":"2011","journal-title":"J Liposome Res"},{"key":"10.1016\/j.cis.2018.01.003_bb0665","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijpharm.2014.11.033","article-title":"Self-assembled drug delivery systems. Part 8: in vitro\/in vivo studies of the nanoassemblies of cholesteryl-phosphonyl gemcitabine","volume":"478","author":"Li","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0670","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.colsurfb.2015.06.033","article-title":"Molecular self-assembly of amphiphilic cyclic phosphoryl gemcitabine with different N-fatty acyl tails and enhanced anticancer effects of the self-assembled nanostructures","volume":"133","author":"Jin","year":"2015","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.cis.2018.01.003_bb0675","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.biopha.2016.02.024","article-title":"Long-circulating and liver-targeted nanoassemblies of cyclic phosphoryl N-dodecanoyl gemcitabine for the treatment of hepatocellular carcinoma","volume":"79","author":"Du","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cis.2018.01.003_bb0680","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3109\/10837450.2010.516439","article-title":"Process optimization by response surface design and characterization study on geniposide pharmacosomes","volume":"17","author":"Yue","year":"2012","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.cis.2018.01.003_bb0685","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4103\/2394-2002.139641","article-title":"Modulation of solubility and dissolution of furosemide by preparation of phospholipid complex","volume":"5","author":"Semalty","year":"2014","journal-title":"Drug Dev Ther"},{"key":"10.1016\/j.cis.2018.01.003_bb0690","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1021\/bi00135a003","article-title":"Spontaneous formation of helical structures from phospholipid-nucleoside conjugates","volume":"31","author":"Itojima","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.cis.2018.01.003_bb0695","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1021\/bc000081o","article-title":"New cationic liposomes for gene transfer into mammalian cells with high efficiency and low toxicity","volume":"12","author":"Choi","year":"2001","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.cis.2018.01.003_bb0700","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1039\/B503302K","article-title":"Nucleoside phosphocholine amphiphile for in vitro DNA transfection","volume":"1","author":"Moreau","year":"2005","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.cis.2018.01.003_bb0705","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1039\/b719280k","article-title":"Nucleoside, nucleotide and oligonucleotide based amphiphiles a successful marriage of nucleic acids with lipids","volume":"6","author":"Gissot","year":"2008","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.cis.2018.01.003_bb0710","first-page":"227","article-title":"Preparation and in vivo behavior of didanosine pharmacosomes in rats","volume":"3","author":"Ping","year":"2005","journal-title":"Chin J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0715","first-page":"617","article-title":"Preparation and properties of acyclovir pharmacosomes","volume":"36","author":"Jin","year":"2005","journal-title":"Chin J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0720","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.colsurfb.2016.09.009","article-title":"Self-assemblies of 5\u2032-cholesteryl-ethyl-phosphoryl zidovudine","volume":"148","author":"Du","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.cis.2018.01.003_bb0725","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcis.2008.07.014","article-title":"Morphological transformation of self-assembled nanostructures prepared from cholesteryl acyl didanosine and the optimal formulation of nanoparticulate systems: effects of solvents, acyl chain length and poloxamer 188","volume":"326","author":"Jin","year":"2008","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.cis.2018.01.003_bb0730","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijpharm.2008.10.009","article-title":"Self-assembled drug delivery systems: part 3. In vitro\/in vivo studies of the self-assembled nanoparticulates of cholesteryl acyl didanosine","volume":"368","author":"Jin","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0735","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijpharm.2009.07.024","article-title":"Self-assembled drug delivery systems. Part 4. In vitro\/in vivo studies of the self-assemblies of cholesteryl-phosphonyl zidovudine","volume":"381","author":"Jin","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0740","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijpharm.2009.11.018","article-title":"Self-assembled drug delivery systems. Part 5: self-assemblies of a bolaamphiphilic prodrug containing dual zidovudine","volume":"386","author":"Jin","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0745","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1021\/mp100457d","article-title":"Combination anti-HIV therapy with the self-assemblies of an asymmetric bolaamphiphilic zidovudine\/didanosine prodrug","volume":"8","author":"Jin","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0750","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.colsurfa.2014.09.020","article-title":"Langmuir monolayers of N-acyl derivatives of adefovir phosphonate at the air\/water interface and molecular self-assembly in water","volume":"462","author":"Jin","year":"2014","journal-title":"Colloids Surf A"},{"key":"10.1016\/j.cis.2018.01.003_bb0755","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1021\/ja909475m","article-title":"Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery","volume":"132","author":"Shen","year":"2010","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cis.2018.01.003_bb0760","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijpharm.2012.03.046","article-title":"Self-assembled drug delivery systems. Part 6: in vitro\/in vivo studies of anticancer N-octadecanoyl gemcitabine nanoassemblies","volume":"430","author":"Jin","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0765","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.colsurfa.2011.11.001","article-title":"Self-assembly of N-acyl derivatives of gemcitabine at the air\/water interface and the formation of nanoscale structures in water","volume":"393","author":"Jin","year":"2012","journal-title":"Colloids Surf A"},{"key":"10.1016\/j.cis.2018.01.003_bb0770","first-page":"1","article-title":"Lipophilic prodrug conjugates allow facile and rapid synthesis of high-loading capacity liposomes without the need for post-assembly purification","volume":"23","author":"Mikhalin","year":"2014","journal-title":"J Liposome Res"},{"key":"10.1016\/j.cis.2018.01.003_bb0775","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s12274-015-0945-1","article-title":"Self-delivery of a peptide-based prodrug for tumor-targeting therapy","volume":"9","author":"Peng","year":"2016","journal-title":"Nano Res"},{"key":"10.1016\/j.cis.2018.01.003_bb0780","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1002\/adfm.201501953","article-title":"Self-assembling prodrugs by precise programming of molecular structures that contribute distinct stability, pharmacokinetics, and antitumor efficacy","volume":"25","author":"Wang","year":"2015","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.cis.2018.01.003_bb0785","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1021\/nl061942q","article-title":"Squalenoyl nanomedicines as potential therapeutics","volume":"6","author":"Couvreur","year":"2006","journal-title":"Nano Lett"},{"key":"10.1016\/j.cis.2018.01.003_bb0790","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1002\/adfm.200800705","article-title":"Novel PEGylated nanoassemblies made of self-assembled squalenoyl nucleoside analogues","volume":"18","author":"Bekkara-Aounallah","year":"2008","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.cis.2018.01.003_bb0795","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.7b00952","article-title":"Low density lipoproteins and human serum albumin as the carriers of squalenoylated drugs: insights from molecular simulations","author":"Yesylevskyy","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.cis.2018.01.003_bb0800","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.msec.2017.08.063","article-title":"Acetal-linked PEGylated paclitaxel prodrugs forming free-paclitaxel-loaded pH-responsive micelles with high drug loading capacity and improved drug delivery","volume":"82","author":"Huang","year":"2018","journal-title":"Mater Sci Eng"},{"key":"10.1016\/j.cis.2018.01.003_bb0805","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bmcl.2014.11.085","article-title":"Functional vesicles formed by anticancer drug assembly","volume":"25","author":"Zhu","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cis.2018.01.003_bb0810","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.colsurfb.2015.08.018","article-title":"Preparation of a multifunctional verapamil-loaded nano-carrier based on a self-assembling PEGylated prodrug","volume":"135","author":"Zhao","year":"2015","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.cis.2018.01.003_bb0815","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.colsurfb.2014.10.035","article-title":"Amphiphilic lipid derivatives of 3\u2032-hydroxyurea-deoxythymidine: preparation, properties, molecular self-assembly, simulation and in vitro anticancer activity","volume":"123","author":"Li","year":"2014","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.cis.2018.01.003_bb0820","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jcis.2016.10.041","article-title":"Nanoassemblies from amphiphilic cytarabine prodrug for leukemia targeted therapy","volume":"487","author":"Liu","year":"2017","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.cis.2018.01.003_bb0825","doi-asserted-by":"crossref","first-page":"10492","DOI":"10.1021\/ja8039019","article-title":"Isostructural self-assembly of 2\u2032-deoxyguanosine derivatives in aqueous and organic media","volume":"130","author":"Garc\u00eda-Arriaga","year":"2008","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cis.2018.01.003_bb0830","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1021\/ol800701j","article-title":"Hexadecameric self-assembled dendrimers built from 2\u2032-deoxyguanosine derivatives","volume":"10","author":"Betancourt","year":"2008","journal-title":"Org Lett"},{"key":"10.1016\/j.cis.2018.01.003_bb0835","first-page":"842","article-title":"Preparation and study in vitro of 20 (S)-protopanaxadiol pharmacosomes","volume":"35","author":"Han","year":"2010","journal-title":"China J Chin Mater Med"},{"key":"10.1016\/j.cis.2018.01.003_bb0840","first-page":"1082","article-title":"Determination of content and entrapment efficiency of 20 (S)-protopanaxadiol in pharmacosomes by RP-HPLC method","volume":"34","author":"Han","year":"2009","journal-title":"China J Chin Mater Med"},{"key":"10.1016\/j.cis.2018.01.003_bb0845","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1134\/S106193481308008X","article-title":"Determination of 20 (S)-protopanaxadiol in rat plasma by LC-MS\/MS and its application to the pharmacokinetic study: a comparative study of its solution and two oral formulations","volume":"68","author":"Han","year":"2013","journal-title":"J Anal Chem"},{"key":"10.1016\/j.cis.2018.01.003_bb0850","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.colsurfb.2008.01.023","article-title":"Monolayers of the lipid derivatives of isoniazid at the air\/water interface and the formation of self-assembled nanostructures in water","volume":"64","author":"Jin","year":"2008","journal-title":"Colloids Surf B Biointerfaces"}],"container-title":["Advances in Colloid and Interface Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001868616303232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001868616303232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T01:01:49Z","timestamp":1719795709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001868616303232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":170,"alternative-id":["S0001868616303232"],"URL":"https:\/\/doi.org\/10.1016\/j.cis.2018.01.003","relation":{},"ISSN":["0001-8686"],"issn-type":[{"value":"0001-8686","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prodrugs, phospholipids and vesicular delivery - An effective triumvirate of pharmacosomes","name":"articletitle","label":"Article Title"},{"value":"Advances in Colloid and Interface Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cis.2018.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}